Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.

An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.

Participants needed: 25
Trial details
Age: 40-65Biological sex: AllType: InterventionalSponsor: TECLens, Inc.Updated: Oct 6, 2025Locations: 1
Eligibility criteria

Adults aged 40-65 years [+4]

Corneal dystrophy, scarring, or prior corneal crosslinking [+8]

Status: Not yet recruiting

Quantitative Refractive Crosslinking in Presbyopia Aged Patients

An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.

Participants needed: 25
Trial details
Age: 40-65Biological sex: AllType: InterventionalSponsor: TECLens, Inc.Updated: Aug 29, 2025Locations: 2
Eligibility criteria

Adults aged 40-65 years [+4]

Corneal dystrophy, scarring, or prior corneal crosslinking [+8]